Financials China Meheco Group Co., Ltd.

Equities

600056

CNE000000Q29

Pharmaceuticals

End-of-day quote Shanghai S.E. 06:00:00 2024-05-05 pm EDT 5-day change 1st Jan Change
11.32 CNY +1.80% Intraday chart for China Meheco Group Co., Ltd. -0.53% +1.34%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 13,431 13,944 15,311 12,619 25,774 16,709
Enterprise Value (EV) 1 11,068 15,095 16,227 14,498 26,864 18,462
P/E ratio 8.7 x 14.2 x 11.7 x 19.5 x 35 x 15.9 x
Yield 3.45% 2.11% 2.57% 1.54% 0.86% 1.88%
Capitalization / Revenue 0.43 x 0.4 x 0.39 x 0.35 x 0.69 x 0.43 x
EV / Revenue 0.36 x 0.43 x 0.41 x 0.4 x 0.71 x 0.48 x
EV / EBITDA 5.3 x 7.28 x 5.68 x 9.21 x 16 x 11.6 x
EV / FCF 24.6 x -23 x 13.9 x 51.8 x 34.4 x -16.3 x
FCF Yield 4.06% -4.34% 7.22% 1.93% 2.91% -6.13%
Price to Book 1.59 x 1.55 x 1.53 x 1.23 x 2.38 x 1.45 x
Nbr of stocks (in thousands) 1,495,880 1,495,880 1,495,880 1,495,880 1,495,880 1,495,880
Reference price 2 8.979 9.321 10.24 8.436 17.23 11.17
Announcement Date 3/27/19 4/21/20 4/28/21 4/29/22 4/28/23 4/26/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 31,006 35,285 39,312 36,234 37,593 38,824
EBITDA 1 2,087 2,073 2,857 1,574 1,683 1,586
EBIT 1 1,881 1,855 2,642 1,375 1,418 1,292
Operating Margin 6.07% 5.26% 6.72% 3.8% 3.77% 3.33%
Earnings before Tax (EBT) 1 2,333 1,693 1,925 940.1 1,196 1,641
Net income 1 1,545 981.3 1,311 647.1 735.7 1,048
Net margin 4.98% 2.78% 3.33% 1.79% 1.96% 2.7%
EPS 2 1.032 0.6560 0.8761 0.4326 0.4918 0.7006
Free Cash Flow 1 449.1 -654.9 1,171 280.1 781.9 -1,132
FCF margin 1.45% -1.86% 2.98% 0.77% 2.08% -2.91%
FCF Conversion (EBITDA) 21.51% - 40.99% 17.79% 46.47% -
FCF Conversion (Net income) 29.07% - 89.36% 43.29% 106.28% -
Dividend per Share 2 0.3098 0.1968 0.2629 0.1298 0.1476 0.2102
Announcement Date 3/27/19 4/21/20 4/28/21 4/29/22 4/28/23 4/26/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - 1,151 916 1,880 1,090 1,753
Net Cash position 1 2,362 - - - - -
Leverage (Debt/EBITDA) - 0.5555 x 0.3206 x 1.194 x 0.6476 x 1.105 x
Free Cash Flow 1 449 -655 1,171 280 782 -1,132
ROE (net income / shareholders' equity) 18.9% 11.9% 11.9% 5.78% 6.91% 9.18%
ROA (Net income/ Total Assets) 5.02% 4.2% 5.24% 2.67% 2.65% 2.2%
Assets 1 30,772 23,358 25,008 24,200 27,815 47,573
Book Value Per Share 2 5.650 6.010 6.690 6.860 7.230 7.730
Cash Flow per Share 2 2.490 1.780 2.380 1.870 2.850 2.590
Capex 1 262 280 318 286 229 363
Capex / Sales 0.84% 0.79% 0.81% 0.79% 0.61% 0.93%
Announcement Date 3/27/19 4/21/20 4/28/21 4/29/22 4/28/23 4/26/24
1CNY in Million2CNY
Estimates
  1. Stock Market
  2. Equities
  3. 600056 Stock
  4. Financials China Meheco Group Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW